Scarica l'app Stockscreener
15.71
4.73%
0.71
Precedente Chiudi:
$15.00
Aprire:
$14.85
Volume 24 ore:
143.49K
Relative Volume:
1.32
Capitalizzazione di mercato:
$257.71M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-0.5244
EPS:
-29.96
Flusso di cassa netto:
-
1 W Prestazione:
+5.79%
1M Prestazione:
+19.47%
6M Prestazione:
+1,147%
1 anno Prestazione:
+1,147%
Intervallo 1D:
$14.68
$15.97
Intervallo di 1 settimana:
$12.71
$16.36
Portata 52W:
$11.75
$17.94
Shoulder Innovations Inc Stock (SI) Company Profile
Nome
Shoulder Innovations Inc
Settore
Industria
Telefono
616-566-0286
Indirizzo
13827 PORT SHELDON STREET, HOLLAND
Confronta SI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
15.71 | 257.71M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Iniziato | BTIG Research | Buy |
| 2025-08-25 | Iniziato | Goldman | Buy |
| 2025-08-25 | Iniziato | Jefferies | Buy |
| 2025-08-25 | Iniziato | Piper Sandler | Overweight |
| 2023-03-06 | Downgrade | Compass Point | Neutral → Sell |
| 2023-03-06 | Downgrade | Wedbush | Neutral → Underperform |
| 2023-03-02 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-03-02 | Downgrade | Compass Point | Buy → Neutral |
| 2023-03-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-03-01 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| 2023-01-09 | Downgrade | Wedbush | Outperform → Neutral |
| 2023-01-06 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Downgrade | Craig Hallum | Buy → Hold |
| 2023-01-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-12 | Reiterato | Wedbush | Outperform |
| 2022-12-05 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-11-10 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-10-26 | Downgrade | Goldman | Buy → Neutral |
| 2022-10-06 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2022-08-04 | Iniziato | BTIG Research | Buy |
| 2022-06-13 | Iniziato | Wells Fargo | Overweight |
| 2022-06-09 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-03-21 | Iniziato | BofA Securities | Buy |
| 2022-01-20 | Aggiornamento | Goldman | Neutral → Buy |
| 2021-12-16 | Iniziato | B. Riley Securities | Buy |
| 2021-11-11 | Iniziato | JP Morgan | Overweight |
| 2021-11-08 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-09-27 | Iniziato | Morgan Stanley | Overweight |
| 2021-06-14 | Iniziato | Goldman | Neutral |
| 2021-01-14 | Downgrade | Barclays | Overweight → Equal Weight |
| 2020-12-22 | Iniziato | Wedbush | Outperform |
| 2020-12-17 | Aggiornamento | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-12-02 | Iniziato | Craig Hallum | Buy |
| 2020-10-16 | Iniziato | Compass Point | Buy |
| 2020-03-16 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-03 | Iniziato | Keefe Bruyette | Mkt Perform |
| 2019-12-02 | Iniziato | Barclays | Overweight |
| 2019-11-18 | Iniziato | Compass Point | Buy |
Mostra tutto
Shoulder Innovations Inc Borsa (SI) Ultime notizie
US-based Shoulder Innovations revenue up 33% to USD 11M in Q2 2025 - Medical Buyer
Shoulder Innovations (NYSE:SI) Receives "Buy" Rating from BTIG Research - MarketBeat
Shoulder Innovations (NYSE:SI) Posts Quarterly Earnings Results - MarketBeat
Analysts Offer Insights on NA Companies: Reddit Inc Class A (RDDT), Solventum Corporation (SOLV) and CG Oncology, Inc. (CGON) - The Globe and Mail
Shoulder Innovations revenue up 33% to USD 11M in Q2 2025 - Medical Buyer
Strong Market Position and Growth Potential Drive Buy Rating for Shoulder Innovations, Inc. - TipRanks
Shoulder Innovations Reports Strong Revenue Growth Amid Losses - TipRanks
SHOULDER INNOVATIONS, INC. SEC 10-Q Report - TradingView
Shoulder Innovations, Inc. Appoints Rick Buchholz to Its Board of Directors - MarketScreener
Shoulder Innovations expects 2025 revenue of $42 million$44 million - MarketScreener
Medical equipment maker Shoulder Innovations Q2 revenue up 33% - MarketScreener
Shoulder Innovations Reports Second Quarter 2025 Financial Results - WV News
Healthcare Pulse: Quarterly Results Due Sept. 9, 2025 - RTTNews
Shoulder Innovations Stock Jumps 8% On NYSE Debut - MSN
Shoulder Innovations, Inc.'s Quiet Period To Expire on September 9th (NYSE:SI) - MarketBeat
Earnings Preview: SI to Report Financial Results Pre-market on September 09 - 富途牛牛
Shoulder Innovations, Inc.’s Quiet Period Set To End on September 9th (NYSE:SI) - Defense World
Shoulder Innovations initiated with an Overweight at Piper Sandler - MSN
Shoulder Innovations, Inc. shares rise 5.18% intraday after Thermo Fisher Scientific completes acquisition of Solventum's Purification & Filtration business. - AInvest
Shoulder Innovations, Inc.’s Quiet Period Will End on September 9th (NYSE:SI) - Defense World
Shoulder Innovations initiated with a Buy at Goldman Sachs - MSN
Shoulder Innovations (NYSE:SI) Rating Lowered to Sell at Wall Street Zen - Defense World
Shoulder Innovations shares rise 2.97% intraday after announcing Q2 2025 earnings release and conference participation. - AInvest
Shoulder Innovations Soars 6.68% on Market Momentum - AInvest
Shoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025 - The Malaysian Reserve
Brokerages Set Shoulder Innovations, Inc. (NYSE:SI) Target Price at $19.60 - Defense World
Shoulder Innovations to Release Q2 2025 Financials and Host Fireside Chat at Morgan Stanley Conference. - AInvest
Morgan Stanley Initiates Coverage of Shoulder Innovations with Overweight Rating - AInvest
Shoulder Innovations initiated with a Buy at Jefferies - MSN
Shoulder Innovations (NYSE:SI) Coverage Initiated by Analysts at Jefferies Financial Group - Defense World
Strong Buy Rating for Shoulder Innovations, Inc. Driven by Market Leadership and High Growth Potential - TipRanks
Shoulder Innovations stock initiated with Overweight rating at Morgan Stanley By Investing.com - Investing.com Canada
Buy Rating for Shoulder Innovations, Inc.: Strong Growth Potential in Shoulder Replacement Market - TipRanks
Heartflow, Inc. shares rise 4.03% intraday after Goldman Sachs and Morgan Stanley initiate coverage on Shoulder Innovations. - AInvest
Piper Sandler initiates coverage on Shoulder Innovations with Overweight rating, PT $18. - AInvest
Shoulder Innovations stock initiated with Buy rating by BTIG - Investing.com
Jefferies Initiates Shoulder Innovations at Buy With $19 Price Target - MarketScreener
Goldman Sachs Initiates Shoulder Innovations at Buy With $20 Price Target - MarketScreener
Jefferies initiates Shoulder Innovations stock with Buy rating on market share gains - Investing.com Canada
Piper Sandler initiates Shoulder Innovations stock with Overweight rating By Investing.com - Investing.com Canada
Goldman Sachs initiates coverage on Shoulder Innovations stock with Buy rating - Investing.com Canada
Shoulder Innovations Expands Surgical Solutions with NYSE Listing—Global Brain Invests - thebridge.jp
Med-tech funding rebounds modestly to $18B through July - BioWorld MedTech
Medical Tech Firm Heartflow Jumps 51% After $317 Million IPO - Bloomberg.com
Medical Tech Firm Heartflow Surges 66% After $317 Million IPO - Bloomberg.com
Heartflow raises USD 317M in IPO - Medical Buyer
Medical Tech Firm Heartflow Prices $317 Million IPO Above Range - Bloomberg.com
Medical Tech Firm Heartflow Raises IPO Target to $300 Million - Bloomberg
Gilde healthcare buys $1.5 million in shoulder innovations (SI) By Investing.com - Investing.com Australia
Gilde healthcare buys $1.5 million in shoulder innovations (SI) - Investing.com
Shoulder Innovations (NYSE:SI) Reaches New 52-Week HighHere's Why - MarketBeat
Shoulder Innovations Inc Azioni (SI) Dati Finanziari
Non sono disponibili dati finanziari per Shoulder Innovations Inc (SI). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.14%
1.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):